Nureca Limited

BSE: 543264 NSE: NURECA
Nureca Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24304MH2016PLC320868 Incorporated 02 November 2016 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: NURECA · BSE: 543264 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹146.96 Cr
▲ 34.02% YoY
EBITDA · FY 2026
₹8.28 Cr
▲ 69.11% YoY
Net profit · FY 2026
₹2.08 Cr
▲ 146.1% YoY
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹71.39 Cr
Satisfied ₹44.12 Lakh
Company age
10 yrs
Est. 2016
Employees · EPFO
117
Latest available

About Nureca Limited

Data last updated: 15 December 2025

Nureca Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 02 November 2016, the company has been in operation for over 10 years.

Registered with ROC Mumbai under CIN L24304MH2016PLC320868. Listed on BSE: 543264 and NSE: NURECA.

Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹10 Cr. Formerly known as Nureca Private Limited. It is led by directors including Rajinder Sharma and Rupinder Tewari.

Last AGM: 16 June 2025. Financial statements filed for year ended 31 March 2025. Office: Office No.101 1St Floor Udyog Bhavan Sonawala Lane Goregaon East, Mumbai, Maharashtra, India – 400063.

As per the financials filed for FY 2025, the company reported a revenue of ₹122.1 Cr, a growth of 19% compared to the previous year.

The company has a workforce of approximately 117 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand - Nureca. As per MCA filings, the company has open charges of ₹71.39 Cr and satisfied charges of ₹44.12 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nureca.com.

Company Details of Nureca Limited
CIN L24304MH2016PLC320868
Registration Number 320868
Incorporation Date 02 November 2016
ROC Mumbai
Listing Status Listed (BSE: 543264, NSE: NURECA)
Company Status Active
Date of Last AGM 16 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Saurabh Goyal Managing Director Rajinder Sharma Whole-Time Director Aryan Goyal Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    nureca.com
  • Social Media
  • Apps
  • Registered Address
    Office No.101 1St Floor Udyog Bhavan Sonawala Lane Goregaon East, Mumbai, Maharashtra, India – 400063
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Nureca Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nureca Limited report

Financials, compliance, directors, charges, ownership and filings for Nureca Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Nureca Limited

Nureca Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24304MH2016PLC320868, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24304MH2016PLC320868 Current
U24304DL2016PTC307786 Previous
U24304MH2016PLC320868 Previous
U24304MH2016PTC320868 Previous

Associated Brands with Nureca Limited

Nureca Limited operates one associated brand: Nureca. These brands represent Nureca Limited's diversified market presence and brand portfolio.

Brand Description Website
Nureca
Health and wellness devices are manufactured by Nureca in India. nureca.com

Competitors & Alternatives of Nureca Limited

Brands and companies operating in the same space as Nureca Limited include Lifegaurd, TenTabs, Meddey Technologies and 4 more.

Competitor Description Location Founded
Lifegaurd Lifegaurd An online platform for healthcare products is provided by Lifegaurd. Chandigarh, India, India 2010
TenTabs TenTabs Online platform selling medical equipment, accessories, and supplies to consumers. Bengaluru, India, India 2018
Meddey Technologies Meddey Technologies Online retailer offering medical devices, health accessories, and diagnostic tools. Delhi, India, India 2016
ClickOnCare ClickOnCare An online retail store for healthcare, wellness, and fitness products. Bengaluru, India, India 2013
Healthizen Healthizen Non-prescription healthcare products, information, and tools are provided online. Mumbai, India, India 2007
Coronation Life Coronation Life Manufactures and sells health products like hot water bottles and medical devices. Delhi, India, India 2022
CoProtex CoProtex Provides reusable copper-infused masks for virus protection and comfort. India 2020

Business Activity of Nureca Limited

Nureca Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********

Auditor Details of Nureca Limited

Nureca Limited is audited by Singhi and Company (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Singhi and Company (ICAI peer reviewed, certificate valid till 2028-08-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Nureca Limited

Nureca Limited is currently managed by 10 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajinder Sharma
Also directs: Nectar Biopharma Private Limited, Nureca Technologies Private Limited
Whole-Time Director 28 May 2022 4 Years 1 Months Current
Rupinder Tewari
Also directs: Nectar Life Sciences Limited
Director 01 Jan 2025 1 Years 6 Months Current
Aryan Goyal
Also directs: Vivaviva Private Limited, Nectar Biopharma Private Limited, Trumom Private Limited and 3 more
Whole-Time Director 28 May 2022 4 Years 1 Months Current
Ruchita Agarwal
Also directs: Aarpee Bio Private Limited
Director 29 Oct 2020 5 Years 8 Months Current
Kuldip Kumar Bhasin
Also directs: Nectar Life Sciences Limited
Director 01 Jan 2025 1 Years 6 Months Current
Charu Singh
Also directs: Alphabetz Ventures Private Limited
Director 21 Oct 2020 5 Years 8 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Nureca Limited FY 2026 filings available

Nureca Limited reported revenue of ₹146.96 Cr (up 34.02% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹146.96 Cr ▲ 34.02%
Profit · FY 2026
₹2.08 Cr ▲ 146.1%
EBITDA · FY 2026
₹8.28 Cr ▲ 69.11%
Revenue₹ Cr · Consolidated0100200300FY 2021: ₹213 Cr213FY 2021FY 2022: ₹256 Cr · +19.7% YoY256+19.7%FY 2022FY 2023: ₹111 Cr · -56.4% YoY111-56.4%FY 2023FY 2024: ₹92 Cr · -17.4% YoY91.9-17.4%FY 2024FY 2025: ₹110 Cr · +19.3% YoY110+19.3%FY 2025FY 2026: ₹147 Cr · +34% YoY147+34%FY 2026
Net Profit₹ Cr · Consolidated-200204060FY 2021: ₹46 Cr46.4FY 2021FY 2022: ₹45 Cr · -3% YoY45-3%FY 2022FY 2023: ₹8 Cr (loss) · -118.3% YoY-8.3FY 2023FY 2024: ₹2 Cr (loss) · +78.3% YoY-1.8FY 2024FY 2025: ₹1 Cr · +147.2% YoY0.8+147.2%FY 2025FY 2026: ₹2 Cr · +146.1% YoY2.1+146.1%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0255075Q1'25: ₹20 Cr · -4.5% YoY20.3-4.5%Q1'25Q2'25: ₹31 Cr · -0.5% YoY31.2-0.5%Q2'25Q3'25: ₹26 Cr · +18.3% YoY26.5+18.3%Q3'25Q4'25: ₹32 Cr · +87% YoY31.7+87%Q4'25Q1'26: ₹34 Cr · +68.6% YoY34.2+68.6%Q1'26Q2'26: ₹72 Cr · +130.6% YoY71.9+130.6%Q2'26Q3'26: ₹40 Cr · +49.8% YoY39.6+49.8%Q3'26Q4'26: ₹35 Cr · +11.5% YoY35.4+11.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹146.96 Cr ₹109.66 Cr ₹91.93 Cr ₹111.32 Cr ₹255.55 Cr ₹213.45 Cr
Other Income ₹8.1 Cr ₹12.44 Cr ₹10.51 Cr ₹7.11 Cr ₹7.7 Cr ₹2.82 Cr
Total Income ₹155.06 Cr ₹122.1 Cr ₹102.44 Cr ₹118.43 Cr ₹263.24 Cr ₹216.27 Cr
Cost of Materials Consumed ₹28.35 Cr ₹11.29 Cr ₹9.76 Cr ₹3.52 Cr ₹0 ₹0
Purchases of Stock-in-Trade ₹73.19 Cr ₹63.68 Cr ₹46.47 Cr ₹41.24 Cr ₹159.55 Cr ₹120.01 Cr
Changes in Inventories -₹8.86 Cr -₹6.96 Cr ₹4.39 Cr ₹30.77 Cr -₹26.93 Cr -₹20.53 Cr
Employee Benefit Expense ₹17.04 Cr ₹15.31 Cr ₹12.2 Cr ₹16.06 Cr ₹9.91 Cr ₹4.58 Cr
Finance Costs ₹1.28 Cr ₹1.21 Cr ₹48.9 Lakh ₹45 Lakh ₹74.1 Lakh ₹1.6 Cr
Depreciation & Amortisation ₹2.02 Cr ₹2.34 Cr ₹2.36 Cr ₹2.39 Cr ₹1.48 Cr ₹42.2 Lakh
Other Expenses ₹37.07 Cr ₹33.88 Cr ₹29.32 Cr ₹34.74 Cr ₹57.5 Cr ₹47.85 Cr
Total Expenses ₹150.08 Cr ₹120.75 Cr ₹104.99 Cr ₹129.17 Cr ₹202.26 Cr ₹153.94 Cr
Profit Before Exceptional Items & Tax ₹4.98 Cr ₹1.34 Cr -₹2.54 Cr -₹10.74 Cr ₹60.98 Cr ₹62.33 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4.98 Cr ₹1.34 Cr -₹2.54 Cr -₹10.74 Cr ₹60.98 Cr ₹62.33 Cr
Total Tax Expense ₹2.9 Cr ₹49.7 Lakh -₹75 Lakh -₹2.49 Cr ₹16.02 Cr ₹15.96 Cr
Net Profit ₹2.08 Cr ₹84.6 Lakh -₹1.79 Cr -₹8.25 Cr ₹44.96 Cr ₹46.37 Cr
  attributable to Owners ₹0 ₹0 - ₹0 ₹0 -
  attributable to NCI ₹0 ₹0 - ₹0 ₹0 -
Other Comprehensive Income ₹7.5 Lakh ₹32.8 Lakh ₹2.2 Lakh -₹6.7 Lakh ₹14.1 Lakh ₹1.1 Lakh
Total Comprehensive Income ₹2.16 Cr ₹1.17 Cr -₹1.77 Cr -₹8.32 Cr ₹45.1 Cr ₹46.39 Cr
EBITDA (computed) ₹8.28 Cr ₹4.9 Cr ₹30.7 Lakh -₹7.9 Cr ₹63.2 Cr ₹64.36 Cr
Basic EPS ₹2.11 ₹0.85 ₹-1.79 ₹-8.25 ₹44.96 ₹62.04
Diluted EPS ₹2.11 ₹0.85 ₹-1.79 ₹-8.25 ₹44.96 ₹62.04
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹196.16 Cr ₹209.98 Cr ₹205.17 Cr ₹206.58 Cr
Non-current Assets ₹81.48 Cr ₹20.02 Cr ₹12.57 Cr ₹20.02 Cr
Current Assets ₹114.68 Cr ₹189.95 Cr ₹192.59 Cr ₹186.56 Cr
Property, Plant & Equipment ₹10.67 Cr ₹4.81 Cr ₹3.12 Cr ₹3.14 Cr
Inventories ₹47.51 Cr ₹39.92 Cr ₹30.85 Cr ₹34.48 Cr
Trade Receivables ₹7.75 Cr ₹3.32 Cr ₹1.62 Cr ₹4.3 Cr
Cash & Equivalents ₹1.46 Cr ₹3.24 Cr ₹14.06 Cr ₹50.4 Lakh
Equity (Net Worth) ₹180.76 Cr ₹194.29 Cr ₹193.11 Cr ₹194.88 Cr
Equity Share Capital ₹9.54 Cr ₹10 Cr ₹10 Cr ₹10 Cr
Borrowings (Non-current) ₹22 Lakh ₹1.05 Cr ₹32.6 Lakh ₹2.03 Cr
Borrowings (Current) ₹49.6 Lakh ₹1.33 Cr ₹15.8 Lakh ₹1.3 Cr
Total Debt (computed) ₹71.6 Lakh ₹2.37 Cr ₹48.4 Lakh ₹3.33 Cr
Current Liabilities ₹13.78 Cr ₹12.4 Cr ₹9.27 Cr ₹8.88 Cr
Total Liabilities ₹15.4 Cr ₹15.69 Cr ₹12.05 Cr ₹11.7 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹3.3 Cr -₹19.08 Cr -₹2.71 Cr ₹10.23 Cr ₹1.4 Cr
Investing Cash Flow ₹14.49 Cr ₹8.44 Cr ₹17.58 Cr -₹16.46 Cr -₹3.09 Cr
Financing Cash Flow -₹19.56 Cr -₹16.9 Lakh -₹1.3 Cr -₹1.51 Cr -₹7.3 Cr
Capital Expenditure ₹6.83 Cr ₹4.32 Cr ₹1.09 Cr ₹39.6 Lakh ₹3.4 Cr
Free Cash Flow (computed) -₹3.53 Cr -₹23.41 Cr -₹3.8 Cr ₹9.83 Cr -₹2.01 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹4.99 Cr
Net Change in Cash -₹1.78 Cr -₹10.82 Cr ₹13.56 Cr -₹7.75 Cr -₹8.99 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹35.41 Cr ₹39.64 Cr ₹71.92 Cr ₹34.18 Cr ₹31.74 Cr ₹26.46 Cr ₹31.19 Cr ₹20.27 Cr ₹16.97 Cr ₹22.37 Cr ₹31.35 Cr ₹21.23 Cr
Other Income ₹1.02 Cr ₹2.19 Cr ₹4.89 Cr ₹2.57 Cr ₹1.99 Cr ₹1.48 Cr ₹3.17 Cr ₹5.79 Cr -₹1.26 Cr ₹5.9 Cr ₹3.2 Cr ₹2.67 Cr
Total Income ₹36.42 Cr ₹41.83 Cr ₹76.81 Cr ₹36.75 Cr ₹33.73 Cr ₹27.94 Cr ₹34.36 Cr ₹26.06 Cr ₹15.71 Cr ₹28.28 Cr ₹34.55 Cr ₹23.9 Cr
Cost of Materials Consumed ₹8.16 Cr ₹10.34 Cr ₹9.85 Cr ₹4.08 Cr ₹3.86 Cr ₹4 Cr ₹2.4 Cr ₹1.04 Cr ₹1.05 Cr ₹4.4 Cr ₹3.02 Cr ₹1.3 Cr
Purchases of Stock-in-Trade ₹12.38 Cr ₹24.86 Cr ₹35.95 Cr ₹18.93 Cr ₹25.16 Cr ₹14.32 Cr ₹12.92 Cr ₹11.28 Cr ₹7.5 Cr ₹4.95 Cr ₹12.35 Cr ₹21.67 Cr
Changes in Inventories ₹90.2 Lakh -₹9.96 Cr ₹19.5 Lakh -₹83.3 Lakh -₹10.04 Cr -₹1.78 Cr ₹4.96 Cr -₹9 Lakh ₹2.63 Cr ₹6.54 Cr ₹3.77 Cr -₹8.55 Cr
Employee Benefit Expense ₹4.1 Cr ₹4.32 Cr ₹8.62 Cr ₹4.45 Cr ₹4.27 Cr ₹3.84 Cr ₹3.63 Cr ₹3.57 Cr ₹3.07 Cr ₹3.28 Cr ₹3.07 Cr ₹2.79 Cr
Finance Costs ₹30 Lakh ₹27.6 Lakh ₹70.7 Lakh ₹24.8 Lakh ₹62 Lakh ₹17.5 Lakh ₹26.9 Lakh ₹15 Lakh ₹17.9 Lakh ₹11 Lakh ₹8.4 Lakh ₹11.6 Lakh
Depreciation & Amortisation ₹44.8 Lakh ₹50 Lakh ₹1.07 Cr ₹53.2 Lakh ₹52.2 Lakh ₹54 Lakh ₹62 Lakh ₹65.6 Lakh ₹60 Lakh ₹59.1 Lakh ₹58.8 Lakh ₹58.3 Lakh
Other Expenses ₹15.64 Cr ₹6.83 Cr ₹14.6 Cr ₹8.11 Cr ₹7.3 Cr ₹10.1 Cr ₹9.64 Cr ₹6.84 Cr ₹7.16 Cr ₹7.47 Cr ₹7.77 Cr ₹6.92 Cr
Total Expenses ₹41.93 Cr ₹37.17 Cr ₹70.98 Cr ₹35.52 Cr ₹31.68 Cr ₹31.19 Cr ₹34.44 Cr ₹23.44 Cr ₹22.18 Cr ₹27.33 Cr ₹30.64 Cr ₹24.83 Cr
Profit Before Exceptional Items & Tax -₹5.51 Cr ₹4.66 Cr ₹5.83 Cr ₹1.23 Cr ₹2.05 Cr -₹3.25 Cr -₹7.5 Lakh ₹2.62 Cr -₹6.47 Cr ₹94.5 Lakh ₹3.91 Cr -₹92.9 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹5.51 Cr ₹4.66 Cr ₹5.83 Cr ₹1.23 Cr ₹2.05 Cr -₹3.25 Cr -₹7.5 Lakh ₹2.62 Cr -₹6.47 Cr ₹94.5 Lakh ₹3.91 Cr -₹92.9 Lakh
Total Tax Expense ₹58.1 Lakh ₹93 Lakh ₹1.39 Cr ₹41.8 Lakh -₹41.6 Lakh -₹45.1 Lakh ₹40.7 Lakh ₹95.7 Lakh -₹2.33 Cr ₹78 Lakh ₹1.02 Cr -₹22.2 Lakh
Net Profit -₹6.09 Cr ₹3.73 Cr ₹4.44 Cr ₹81.3 Lakh ₹2.47 Cr -₹2.8 Cr -₹48.2 Lakh ₹1.66 Cr -₹4.15 Cr ₹16.5 Lakh ₹2.89 Cr -₹70.7 Lakh
  attributable to Owners ₹0 ₹0 ₹0 - ₹0 ₹0 - - - - - ₹0
  attributable to NCI ₹0 ₹0 ₹0 - ₹0 ₹0 - - - - - ₹0
Other Comprehensive Income ₹7.5 Lakh ₹0 ₹0 ₹0 ₹30.6 Lakh ₹40,000 ₹80,000 ₹1 Lakh ₹6.8 Lakh -₹1.4 Lakh -₹90,000 -₹2.2 Lakh
Total Comprehensive Income -₹6.02 Cr ₹3.73 Cr ₹4.44 Cr ₹81.3 Lakh ₹2.77 Cr -₹2.8 Cr -₹47.4 Lakh ₹1.67 Cr -₹4.08 Cr ₹15.1 Lakh ₹2.89 Cr -₹72.9 Lakh
EBITDA (computed) -₹4.76 Cr ₹5.44 Cr ₹7.6 Cr ₹2.01 Cr ₹3.19 Cr -₹2.54 Cr ₹81.4 Lakh ₹3.43 Cr -₹5.69 Cr ₹1.65 Cr ₹4.58 Cr -₹23 Lakh
Basic EPS ₹-6.45 ₹3.91 ₹4.44 ₹0.81 ₹2.47 ₹-2.80 ₹-0.48 ₹1.66 ₹-4.15 ₹0.16 ₹2.90 ₹-0.71
Diluted EPS ₹-6.45 ₹3.91 ₹4.44 ₹0.81 ₹2.47 ₹-2.80 ₹-0.48 ₹1.66 ₹-4.15 ₹0.16 ₹2.90 ₹-0.71
Latest 12 quarters shown of 21 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹147.21 Cr ₹114.64 Cr ₹94.52 Cr ₹111.9 Cr ₹255.55 Cr ₹213.33 Cr
Other Income ₹8.32 Cr ₹12.54 Cr ₹10.56 Cr ₹7.17 Cr ₹7.72 Cr ₹2.82 Cr
Total Income ₹155.53 Cr ₹127.18 Cr ₹105.09 Cr ₹119.06 Cr ₹263.27 Cr ₹216.15 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹111.62 Cr ₹86.49 Cr ₹63.19 Cr ₹47.08 Cr ₹159.53 Cr ₹119.9 Cr
Changes in Inventories -₹9.6 Cr -₹6.8 Cr ₹4.16 Cr ₹30.72 Cr -₹26.92 Cr -₹20.53 Cr
Employee Benefit Expense ₹15.43 Cr ₹14.36 Cr ₹11.57 Cr ₹15.51 Cr ₹9.83 Cr ₹4.58 Cr
Finance Costs ₹1.03 Cr ₹1.12 Cr ₹46 Lakh ₹43.1 Lakh ₹73.1 Lakh ₹1.6 Cr
Depreciation & Amortisation ₹1.85 Cr ₹2.15 Cr ₹2.24 Cr ₹2.3 Cr ₹1.43 Cr ₹40.9 Lakh
Other Expenses ₹32.36 Cr ₹30.33 Cr ₹26.74 Cr ₹33.98 Cr ₹57.33 Cr ₹47.7 Cr
Total Expenses ₹152.69 Cr ₹127.64 Cr ₹108.35 Cr ₹130.02 Cr ₹201.94 Cr ₹153.66 Cr
Profit Before Exceptional Items & Tax ₹2.84 Cr -₹46 Lakh -₹3.27 Cr -₹10.96 Cr ₹61.33 Cr ₹62.49 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹2.84 Cr -₹46 Lakh -₹3.27 Cr -₹10.96 Cr ₹61.33 Cr ₹62.49 Cr
Total Tax Expense ₹2.54 Cr ₹20.8 Lakh -₹82.7 Lakh -₹2.54 Cr ₹16.02 Cr ₹15.96 Cr
Net Profit ₹29.7 Lakh -₹66.8 Lakh -₹2.44 Cr -₹8.42 Cr ₹45.31 Cr ₹46.53 Cr
Other Comprehensive Income ₹5.1 Lakh ₹28.8 Lakh ₹3.9 Lakh -₹5.8 Lakh ₹14.2 Lakh ₹90,000
Total Comprehensive Income ₹34.8 Lakh -₹38 Lakh -₹2.4 Cr -₹8.48 Cr ₹45.45 Cr ₹46.54 Cr
EBITDA (computed) ₹5.72 Cr ₹2.81 Cr -₹56.7 Lakh -₹8.23 Cr ₹63.49 Cr ₹64.5 Cr
Basic EPS ₹0.30 ₹-0.67 ₹-2.44 ₹-8.42 ₹45.31 ₹62.25
Diluted EPS ₹0.30 ₹-0.67 ₹-2.44 ₹-8.42 ₹45.31 ₹62.25
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹193.54 Cr ₹206.16 Cr ₹204.33 Cr ₹206.68 Cr
Non-current Assets ₹83.07 Cr ₹21.78 Cr ₹15.19 Cr ₹22.68 Cr
Current Assets ₹110.47 Cr ₹184.38 Cr ₹189.15 Cr ₹184 Cr
Property, Plant & Equipment ₹9.39 Cr ₹3.63 Cr ₹2.39 Cr ₹2.63 Cr
Inventories ₹45.41 Cr ₹35.55 Cr ₹28.76 Cr ₹32.83 Cr
Trade Receivables ₹9.78 Cr ₹4.53 Cr ₹1.81 Cr ₹4.27 Cr
Cash & Equivalents ₹1.4 Cr ₹3.19 Cr ₹13.96 Cr ₹40 Lakh
Equity (Net Worth) ₹177.16 Cr ₹192.48 Cr ₹192.86 Cr ₹195.26 Cr
Equity Share Capital ₹9.54 Cr ₹10 Cr ₹10 Cr ₹10 Cr
Borrowings (Non-current) ₹22 Lakh ₹1.05 Cr ₹32.6 Lakh ₹0
Borrowings (Current) ₹44.7 Lakh ₹47.6 Lakh ₹7.5 Lakh ₹0
Total Debt (computed) ₹66.7 Lakh ₹1.52 Cr ₹40.1 Lakh ₹0
Current Liabilities ₹14.8 Cr ₹10.44 Cr ₹8.77 Cr ₹8.62 Cr
Total Liabilities ₹16.38 Cr ₹13.68 Cr ₹11.47 Cr ₹11.42 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹31.9 Lakh -₹18.55 Cr -₹3 Cr ₹12.05 Cr ₹1.83 Cr
Investing Cash Flow ₹16.5 Cr ₹8.56 Cr ₹17.84 Cr -₹18.3 Cr -₹3.37 Cr
Financing Cash Flow -₹18.61 Cr -₹78.8 Lakh -₹1.28 Cr -₹1.51 Cr -₹7.3 Cr
Capital Expenditure ₹5.37 Cr ₹3.99 Cr ₹49.7 Lakh ₹23.5 Lakh ₹3.26 Cr
Free Cash Flow (computed) -₹5.05 Cr -₹22.54 Cr -₹3.49 Cr ₹11.82 Cr -₹1.43 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹4.99 Cr
Net Change in Cash -₹1.79 Cr -₹10.77 Cr ₹13.56 Cr -₹7.76 Cr -₹8.84 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹35.41 Cr ₹39.64 Cr ₹72.17 Cr ₹34.32 Cr ₹31.75 Cr ₹27.21 Cr ₹32.37 Cr ₹23.31 Cr ₹19.56 Cr ₹22.37 Cr ₹31.35 Cr ₹21.23 Cr
Other Income ₹1.06 Cr ₹2.29 Cr ₹4.97 Cr ₹2.59 Cr ₹2 Cr ₹1.52 Cr ₹3.21 Cr ₹5.82 Cr -₹1.25 Cr ₹5.92 Cr ₹3.21 Cr ₹2.69 Cr
Total Income ₹36.47 Cr ₹41.93 Cr ₹77.14 Cr ₹36.92 Cr ₹33.75 Cr ₹28.73 Cr ₹35.58 Cr ₹29.13 Cr ₹18.31 Cr ₹28.3 Cr ₹34.56 Cr ₹23.92 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹23.05 Cr ₹38.27 Cr ₹50.3 Cr ₹25.39 Cr ₹30.88 Cr ₹20.9 Cr ₹17.88 Cr ₹16.83 Cr ₹12.82 Cr ₹10.45 Cr ₹16.49 Cr ₹23.43 Cr
Changes in Inventories ₹62.4 Lakh -₹10.15 Cr -₹7.4 Lakh -₹1.03 Cr -₹10.19 Cr -₹1.65 Cr ₹5.07 Cr -₹3.7 Lakh ₹2.35 Cr ₹6.61 Cr ₹3.66 Cr -₹8.47 Cr
Employee Benefit Expense ₹3.66 Cr ₹3.9 Cr ₹7.87 Cr ₹4.08 Cr ₹3.98 Cr ₹3.6 Cr ₹3.39 Cr ₹3.38 Cr ₹2.91 Cr ₹3.11 Cr ₹2.91 Cr ₹2.64 Cr
Finance Costs ₹24.2 Lakh ₹17.7 Lakh ₹61.2 Lakh ₹20.2 Lakh ₹59.4 Lakh ₹14.1 Lakh ₹25.2 Lakh ₹12.8 Lakh ₹17.1 Lakh ₹10.1 Lakh ₹8 Lakh ₹10.8 Lakh
Depreciation & Amortisation ₹43.2 Lakh ₹45.5 Lakh ₹96.1 Lakh ₹47.9 Lakh ₹47.5 Lakh ₹49.3 Lakh ₹57.3 Lakh ₹61.2 Lakh ₹56.4 Lakh ₹56.2 Lakh ₹56 Lakh ₹55.6 Lakh
Other Expenses ₹14.61 Cr ₹5.23 Cr ₹12.52 Cr ₹6.96 Cr ₹6.51 Cr ₹9.09 Cr ₹8.68 Cr ₹6.05 Cr ₹6.25 Cr ₹6.63 Cr ₹7.25 Cr ₹6.62 Cr
Total Expenses ₹42.62 Cr ₹37.88 Cr ₹72.2 Cr ₹36.08 Cr ₹32.25 Cr ₹32.57 Cr ₹35.85 Cr ₹26.97 Cr ₹25.06 Cr ₹27.47 Cr ₹30.95 Cr ₹24.88 Cr
Profit Before Exceptional Items & Tax -₹6.15 Cr ₹4.05 Cr ₹4.94 Cr ₹83.3 Lakh ₹1.5 Cr -₹3.85 Cr -₹27.1 Lakh ₹2.16 Cr -₹6.74 Cr ₹83 Lakh ₹3.61 Cr -₹96.3 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹6.15 Cr ₹4.05 Cr ₹4.94 Cr ₹83.3 Lakh ₹1.5 Cr -₹3.85 Cr -₹27.1 Lakh ₹2.16 Cr -₹6.74 Cr ₹83 Lakh ₹3.61 Cr -₹96.3 Lakh
Total Tax Expense ₹47.3 Lakh ₹81.7 Lakh ₹1.25 Cr ₹28.1 Lakh -₹57.4 Lakh -₹55.9 Lakh ₹37.5 Lakh ₹96.6 Lakh -₹2.33 Cr ₹75.2 Lakh ₹97 Lakh -₹22.1 Lakh
Net Profit -₹6.63 Cr ₹3.23 Cr ₹3.69 Cr ₹55.2 Lakh ₹2.07 Cr -₹3.29 Cr -₹64.6 Lakh ₹1.2 Cr -₹4.41 Cr ₹7.8 Lakh ₹2.64 Cr -₹74.2 Lakh
Other Comprehensive Income ₹5.1 Lakh ₹0 ₹0 ₹0 ₹25.8 Lakh ₹1 Lakh ₹1 Lakh ₹1 Lakh ₹8.2 Lakh -₹1.4 Lakh -₹1.5 Lakh -₹1.4 Lakh
Total Comprehensive Income -₹6.57 Cr ₹3.23 Cr ₹3.69 Cr ₹55.2 Lakh ₹2.33 Cr -₹3.28 Cr -₹63.6 Lakh ₹1.21 Cr -₹4.33 Cr ₹6.4 Lakh ₹2.62 Cr -₹75.6 Lakh
EBITDA (computed) -₹5.48 Cr ₹4.68 Cr ₹6.51 Cr ₹1.51 Cr ₹2.57 Cr -₹3.21 Cr ₹55.4 Lakh ₹2.9 Cr -₹6.01 Cr ₹1.49 Cr ₹4.25 Cr -₹29.9 Lakh
Basic EPS ₹-6.95 ₹3.39 ₹3.69 ₹0.55 ₹2.07 ₹-3.29 ₹-0.65 ₹1.19 ₹-4.41 ₹0.08 ₹2.64 ₹-0.74
Diluted EPS ₹-6.95 ₹3.39 ₹3.69 ₹0.55 ₹2.07 ₹-3.29 ₹-0.65 ₹1.19 ₹-4.41 ₹0.08 ₹2.64 ₹-0.74
Latest 12 quarters shown of 21 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Nureca Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Nureca Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 68.09%, foreign institutional investors hold 0.28%, domestic institutional investors hold 0.24%, retail and other public shareholders hold 31.39% of Nureca Limited. The company had 34,558 shareholders on record.

Promoters: 68.09%DII (Domestic Institutional): 0.24%FII (Foreign Institutional): 0.28%Retail & Others: 31.39%
Mar 2026
QUARTER
68.09% Promoters
0.24% DII (Domestic Institutional)
0.28% FII (Foreign Institutional)
31.39% Retail & Others
Promoter holding - history
Now 68.09% · Mar 2026High 70.00% · Feb 2021Low 62.98% · Dec 2022
61%63.5%66%68.5%71%Feb 2021Mar 2022Jun 2023Sep 2024Dec 2025Feb 2021: 70.00%Mar 2021: 70.00%Jun 2021: 70.00%Sep 2021: 70.00%Dec 2021: 70.00%Mar 2022: 70.00%Jun 2022: 70.00%Sep 2022: 70.00%Dec 2022: 62.98%Mar 2023: 62.98%Jun 2023: 62.98%Sep 2023: 63.24%Dec 2023: 63.24%Mar 2024: 63.24%Jun 2024: 63.24%Sep 2024: 63.77%Dec 2024: 64.06%Mar 2025: 64.30%Jun 2025: 64.33%Sep 2025: 64.97%Dec 2025: 64.97%Jan 2026: 68.09%Mar 2026: 68.09%70.00%62.98%68.09%
Shareholding trend - last 6 quarters
Mar 2026Jan 2026Dec 2025Sep 2025Jun 2025Mar 2025
Promoters68.09%68.09%64.97%64.97%64.33%64.30%
Public31.91%31.91%35.03%35.03%35.67%35.70%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Promoters68.09%64.30%63.24%62.98%70.00%70.00%
Public31.91%35.70%36.76%37.02%30.00%30.00%
Promoter change (YoY, %pts)+3.79+1.06+0.26-7.02+0.00-

Board & Governance of Nureca Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Nureca Limited has 8 directors - 5 independent and 3 executive. The board is chaired by SAURABH GOYAL.

DirectorPositionOn board sinceListed boards
SAURABH GOYAL Executive Director · MD · Chairperson 2017-02-11 1
VIJAY KUMAR SHARMA Non-Executive - Independent Director 2020-10-21 4
CHARU SINGH Non-Executive - Independent Director 2020-10-21 1
RUCHITA AGARWAL Non-Executive - Independent Director 2020-10-29 1
ARYAN GOYAL Executive Director 2022-05-28 1
RAJINDER SHARMA Executive Director 2022-05-28 1
RUPINDER TEWARI Non-Executive - Independent Director 2025-01-01 2
KULDIP KUMAR BHASIN Non-Executive - Independent Director 2025-01-01 2
Board Committees
CommitteeMembers
Audit Committee CHARU SINGH (Chairperson), RUCHITA AGARWAL, RUPINDER TEWARI, KULDIP KUMAR BHASIN
Nomination and remuneration committee CHARU SINGH (Chairperson), RUCHITA AGARWAL, KULDIP KUMAR BHASIN
Stakeholders Relationship Committee CHARU SINGH (Chairperson), RUCHITA AGARWAL, SAURABH GOYAL
Risk Management Committee RUCHITA AGARWAL (Chairperson), CHARU SINGH, SAURABH GOYAL, RUPINDER TEWARI
Corporate Social Responsibility Committee SAURABH GOYAL (Chairperson), CHARU SINGH, RUPINDER TEWARI
Management committee ARYAN GOYAL (Chairperson), NARESH GUPTA, SAURABH GOYAL
Buyback committee ARYAN GOYAL, NARESH GUPTA, SAURABH GOYAL, RAJINDER SHARMA, NISHU KANSAL

Group Structure of Nureca Limited

Nureca Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Nureca Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Nureca Technologies Private Limited U33110PB2020PTC051368 -
Nureca Healthcare Private Limited U33119PB2020PTC051608 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Nureca Limited

Open charges
₹71.39 Cr
Satisfied charges
₹44.12 Lakh
Breakdown by lending institutions
Others₹71.39 Cr
Latest charge details
DateLenderAmountStatus
30 Apr 2024 Others ₹19.99 Cr Open
26 Apr 2024 Others ₹1 Cr Open
16 Oct 2023 Others ₹43 Lakh Open
04 Jun 2021 Others ₹49.97 Cr Open
19 Feb 2025 Others ₹44.12 Lakh Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Nureca Limited

Nureca Limited has a workforce of 117 employees as of Mar 27, 2024.

Employee count
117
Active EPFO establishments
1
Employee growth
-16.43%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Nureca Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Nureca Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Nureca Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Nureca Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Nureca Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Nureca Limited

MSME Payment Delays by Nureca Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Nureca Limited

Subsidiaries & Group Companies of Nureca Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Nureca Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Nureca Limited

MCA Filings & Documents of Nureca Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Nureca Limited

Charges
30 Sep 2025
A charge with Others of Rs. 19.99 Cr registered on 30 Apr 2024 with Charge ID 100922220 was modified on 30 Sep 2025.
Charges
16 Sep 2025
A charge registered on 19 Feb 2025 via Charge ID 101077365 with Others was fully satisfied on 16 Sep 2025.
Activity
16 Jun 2025
Nureca Limited last Annual general meeting of members was held on 16 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Nureca Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
22 Feb 2025
Nishu Kansal was appointed as a Company Secretary on 22 Feb 2025 & has been associated with this company since 1 year 4 months.
Charges
19 Feb 2025
A charge with Others amounted to Rs. 0.44 Cr with Charge ID 101077365 was registered on 19 Feb 2025.

Frequently Asked Questions about Nureca Limited

Nureca Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 02 November 2016 (10+ years old) and is registered under CIN L24304MH2016PLC320868. Listed on BSE: 543264 and NSE: NURECA. The company has 117 employees.

Nureca Limited reported revenue of ₹122.1 Cr for FY 2025 (up 19.00% YoY).

The current directors of Nureca Limited are:

The primary industry of Nureca Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.

Yes. Nureca Limited is listed on both BSE (code: 543264) and NSE (symbol: NURECA).

Nureca Limited can be reached at the registered office: Office No.101 1St Floor Udyog Bhavan Sonawala Lane Goregaon East, Mumbai, Maharashtra, India – 400063, or through the website nureca.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available